Filing
Spy
Filing
Spy
Home
About
NBSE
Neubase Therapeutics Inc
Biotechnology company
CUSIP: 64132K102
Healthcare
US
1 holder
Ownership
Activity
2022 Q3
3 of 15 quarters
Total Value
$1.08M
Total Shares
2.73M
Net Share Change
0
Activity
No changes
Investor
Value
Shares
Weight
Change
Greenlight Capital
$1.08M
2.73M
0.1%
Unchanged
Greenlight Capital
$1.08M
2.73M shares
Unchanged
NBSE — Neubase Therapeutics Inc - FilingSpy